In an era where medical information is often fragmented and difficult to parse, the Lymphoma Research Foundation (LRF) is bridging the gap between clinical research and patient empowerment. On Thursday, August 20, 2026, the organization will host "Lymphoma Talk," an intensive, in-person educational program designed to provide patients, survivors, and their caregivers with the tools and knowledge necessary to navigate their unique health journeys. Held at the scenic westdrift Manhattan Beach in California, the event serves as a focal point for the regional lymphoma community to engage directly with leading experts in the field.
The Core Mission: Bridging Knowledge and Care
The Lymphoma Talk initiative is a hallmark of the LRF’s commitment to patient advocacy. By moving away from digital-only engagement, the Foundation aims to foster a communal environment where attendees can ask questions, share experiences, and receive clarity on complex medical topics.
The event is specifically tailored for those currently battling lymphoma, individuals in remission, and the essential support networks—family members and friends—who walk the path alongside them. The program is structured into a two-hour intensive evening session, ensuring that participants receive high-level medical insights without the fatigue associated with day-long conferences.
Chronology of the Evening: A Detailed Agenda
The evening is carefully curated to maximize the utility of the time spent. Attendees are invited to arrive at 6:00 PM PT for check-in, providing a moment for community building before the formal program commences.
6:00 – 6:15 PM: Arrival and Registration
The opening quarter-hour allows for registration and networking. The venue, westdrift Manhattan Beach (located at 1400 Parkview Avenue, Manhattan Beach, CA), offers a tranquil and professional setting conducive to the serious nature of the discussions to follow.
6:15 – 7:15 PM: Dinner and Keynote
Following the check-in, guests will be served a buffet dinner. This segment is designed to encourage conversation among peers, fostering a support system that often persists long after the event concludes. During this time, a keynote presentation will be delivered by a prominent expert in the field of lymphoma. While the specific speakers are currently being finalized, the LRF consistently features top-tier hematologists and oncologists who bring the latest clinical research to the forefront.
7:15 – 8:30 PM: Breakout Educational Sessions
The heart of the program lies in the final hour and fifteen minutes. Attendees will have the opportunity to select one of three specialized breakout sessions. These sessions are designed to drill down into specific sub-types of lymphoma, emerging treatment modalities, or practical aspects of survivorship. By offering a choice, the LRF ensures that participants can focus on the information most relevant to their specific diagnosis or personal needs.
8:30 PM: Formal Conclusion
The program will wrap up promptly at 8:30 PM, allowing attendees to depart with a clearer understanding of their treatment options and a renewed sense of connection to the broader medical community.
Navigating Logistics and Health Protocols
Given the specific needs of the immunocompromised community, the LRF places a high priority on safety. This is an strictly in-person event, and all attendees are encouraged to familiarize themselves with the Lymphoma Research Foundation’s Health and Safety Protocol.
For those who wish to attend, registration is essential. Prospective attendees can secure their place by contacting the Lymphoma Resource Center at 800-500-9976 or by sending an inquiry to the dedicated email support team. The LRF also maintains an open door for industry professionals. If a representative from the pharmaceutical sector wishes to attend and their organization is not currently listed as a program partner, they are encouraged to contact the Foundation to discuss sponsorship opportunities.
The Significance of Expert-Led Education
The value of "Lymphoma Talk" lies in the direct access it provides to experts who are on the cutting edge of research. In the realm of hematological malignancies, the landscape is shifting rapidly. New drug approvals, advancements in chimeric antigen receptor (CAR) T-cell therapy, and the refinement of targeted immunotherapies mean that a patient’s treatment plan can become outdated in a matter of months.
By attending these forums, patients are empowered to engage in "shared decision-making" with their own primary oncologists. When a patient arrives at their next clinical appointment equipped with the knowledge gained from an LRF event, they are better positioned to ask the right questions—whether about clinical trial eligibility, side-effect management, or the nuance of their specific genetic markers.
Disclaimer and Scope of Information
As with any major medical educational initiative, it is vital to understand the scope of the information provided. The Lymphoma Research Foundation operates as a U.S.-based nonprofit. Consequently, the information presented at "Lymphoma Talk" is intended for a U.S.-based audience and focuses on treatments and medications approved by the U.S. Food and Drug Administration (FDA).
It is critical for participants to recognize that these sessions are for educational purposes only. They do not constitute medical advice, diagnosis, or treatment. Attending a session does not establish a patient-provider relationship between the attendee and the speakers. The Foundation strongly advises that every participant consult with their own medical team before making any changes to their treatment regimen.
For those residing outside the United States, the Foundation recommends engaging with the Lymphoma Coalition. As a global network of patient organizations, the Coalition provides resources and guidance that are specifically tailored to non-U.S. healthcare systems and international regulatory environments.
Intellectual Property and Ethical Standards
The content produced by the Lymphoma Research Foundation is protected under international intellectual property laws. All presentations, handouts, and digital resources shared during the event are the property of the Foundation and cannot be reproduced or distributed without explicit written consent. This ensures the integrity of the information and protects the Foundation’s ability to continue providing high-quality, verified data to the public.
Furthermore, the Foundation maintains a strict policy of neutrality. While the event is made possible through the generous support of educational grants—such as those from Gold Supporter Genentech/Roche—the Foundation does not endorse specific products, treatments, or services. The inclusion of sponsor logos acknowledges their contribution to the mission of patient education but does not imply a commercial bias.
Implications for the Patient Journey
The implications of attending such an event are profound. For many, a diagnosis of lymphoma is isolating. It can feel as though the world has stopped while the rest of life continues at a dizzying pace. By participating in "Lymphoma Talk," patients are reminded that they are part of a larger community of survivors.
The social aspect of the evening is as important as the clinical data. Speaking with others who have navigated the same chemotherapy regimens, who have managed the same symptoms, or who have celebrated the same milestones in remission provides a psychological benefit that is impossible to replicate in a doctor’s office.
Furthermore, the structure of the event—featuring a keynote address followed by breakout sessions—models the "whole-person" approach to oncology. It acknowledges that a patient’s health involves not just the eradication of cancer cells, but also the management of their quality of life, their mental well-being, and their ability to navigate the complex administrative and financial realities of modern healthcare.
Looking Forward: The Role of Support
As the August 20, 2026, date approaches, the Lymphoma Research Foundation continues to refine the programming to ensure it reflects the most current advancements in the field. The commitment from supporters like Genentech and other corporate partners highlights the industry’s recognition that an informed patient is a stronger partner in their own care.
For anyone currently impacted by lymphoma, this event in Manhattan Beach is an opportunity to reclaim agency. Whether you are seeking information on a new line of treatment, looking for strategies to manage fatigue, or simply wanting to be in a room with others who understand the nuances of the "lymphoma life," the "Lymphoma Talk" program provides the necessary platform to move forward with confidence and clarity.
For additional information on the speakers, the specific topics of the breakout sessions, or to secure your registration, please contact the Lymphoma Research Foundation’s resource center at your earliest convenience. The journey through lymphoma is challenging, but with the right information and the right community, it is one that no one has to navigate alone.
